Silver Book Fact

A recent study demonstrated that the cost of treating cardiovascular disease could rise by 64% to 84% by 2025.

Reference

Title
The Future of Cardiology: Utilization and costs of care
Publication
J Am Coll Cardiol
Publication Date
2000
Authors
Steinwachs D, Collins-Nakai R, Cohn L, Garson A, et al
Volume & Issue
Volume 35, Issue 4
Pages
1092-9
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Economic Burden

Related Facts

  • Mitral valve disease costs
    Mitral valve disease (symptomatic and asymptomatic) costs the U.S. at least $13.2 billion in direct healthcare expenditures each year.  
  • On average, every 40 seconds, someone in the United States has a stroke.  
  • In 2008, cardiovascular disease accounted for 32.8% of all deaths in the U.S.–811,940, or 1 of every 3 deaths in the U.S.  
  • AFib, an economic burden
    AFib is a major economic burden for the U.S. with at least $6.65 billion in healthcare costs attributable to the disease each year. This estimate may be low. One study…  
  • 71.5% of 65-year-olds with coronary heart disease have 3 or more comorbidities and physical limitations–only 3.8% have none.